TheraRadar
← Back
Data updated: Mar 29, 2026

IPR

Infectious DiseaseCardiovascularOphthalmology
Pharma

IPR is a pharmaceutical company focused on Infectious Disease, Cardiovascular, Ophthalmology.

1997
Since
1
Drugs
-
Trials
0
Approved (2yr)

Key Drugs

No active drugs

Top Drug Revenues Pro

Loading...

Revenue Over Time Pro

Loading...

Recent Activity

No recent activity
SEC Filings Pro
Loading...

Therapeutic Areas

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

Infectious Disease 73%
0 drugs Phase 2: 4 Phase 1: 3
Cardiovascular 13%
0 drugs Phase 2: 1
Ophthalmology 13%
0 drugs Phase 2: 1

Pipeline Forecast

Loading...

Upcoming Trial Milestones Pro

Loading...

Patent Cliff Pro

Loading...

Competitors by Therapeutic Area

Baxter specialty
Infectious Disease, Cardiovascular, Ophthalmology
B BRAUN specialty
Infectious Disease, Ophthalmology, Cardiovascular
BAUSCH AND LOMB specialty
Ophthalmology, Cardiovascular, Infectious Disease
FOUGERA PHARMS other
Ophthalmology, Infectious Disease, Cardiovascular
Novartis big-pharma
Cardiovascular, Ophthalmology